Continuous intracranial administration of suberoylanilide hydroxamic acid (SAHA) inhibits tumor growth in an orthotopic glioma model

Hasan C. Ugur, Naren Ramakrishna, Lorenzo Bello, Lata G. Menon, Seung Ki Kim, Peter M. Black, Rona S. Carroll

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Continuous intracranial administration of suberoylanilide hydroxamic acid (SAHA) inhibits tumor growth in an orthotopic glioma model'. Together they form a unique fingerprint.

Medicine & Life Sciences